SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Morgan Stanley Maintains Overweight on MyoKardia, Raises Price Target to $117

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $87 to $117.

Benzinga · 05/12/2020 12:24

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $87 to $117.